MCPHERSON'S LIMITED (MCP)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

MCP - MCPHERSON'S LIMITED

FNArena Sector : Health & Nutrition
Year End: June
GICS Industry Group : Consumer Durables & Apparel
Debt/EBITDA: 1.76
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.435

22 Sep
2023

0.000

OPEN

$0.44

0.000

HIGH

$0.44

12,800

LOW

$0.44

TARGET
$0.56 28.7% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
CLV . EBO . EXL . SIG .
FNARENA'S MARKET CONSENSUS FORECASTS
MCP: 1
Title FY22
Actual		 FY23
Actual		 FY24
Forecast		 FY25
Forecast
EPS (cps) xxx - 3.5 4.3 xxx
DPS (cps) xxx 3.0 3.5 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx - 40.0% 16.7% xxx
PE Ratio xxx N/A 10.2 xxx
Dividend Yield xxx N/A 8.0% xxx
Div Pay Ratio(%) xxx N/A 81.4% xxx

Dividend yield today if purchased 3 years ago: 1.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 6.90

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 04/09 - ex-div 1c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx-3.5
DPS All xxxxxxxxxxxxxxx3.0
Sales/Revenue xxxxxxxxxxxxxxx210.3 M
Book Value Per Share xxxxxxxxxxxxxxx76.0
Net Operating Cash Flow xxxxxxxxxxxxxxx6.5 M
Net Profit Margin xxxxxxxxxxxxxxx-2.41 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx-4.40 %
Return on Invested Capital xxxxxxxxxxxxxxx-3.86 %
Return on Assets xxxxxxxxxxxxxxx-2.49 %
Return on Equity xxxxxxxxxxxxxxx-4.40 %
Return on Total Capital xxxxxxxxxxxxxxx5.96 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-1.0 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx5 M
Long Term Debt xxxxxxxxxxxxxxx21 M
Total Debt xxxxxxxxxxxxxxx25 M
Goodwill - Gross xxxxxxxxxxxxxxx34 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx7 M
Price To Book Value xxxxxxxxxxxxxxx0.52

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx1.8 M
Capex % of Sales xxxxxxxxxxxxxxx0.88 %
Cost of Goods Sold xxxxxxxxxxxxxxx152 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx50 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx-

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Ord Minnett

25/08/2023

3

Hold

$0.56

28.74%

McPherson's reported FY23 results that were ahead of expectations. Declining sales for the A'kin and Multix brands were well flagged, the broker points out, contributing to a -2% decline in yearly group sales.

New management will inherit a business that has #1 and #2 brands in multiple categories with broad distribution into grocery and pharmacy channels.

The broker also observes the balance sheet is in "reasonable shape" and there are no major expenditure programs on the horizon. Hold rating retained. Target edges down to $0.56 from $0.60.

FORECAST
Ord Minnett forecasts a full year FY24 dividend of 3.50 cents and EPS of 4.30 cents.
Ord Minnett forecasts a full year FY25 dividend of 3.80 cents and EPS of 4.40 cents.
Access Stockbroker Research History >

MCP STOCK CHART

FNArena News on MCP

1
Australian Broker Call *Extra* Edition – Sep 08, 2023

Sep 08 2023 - Daily Market Reports
2
FNArena Corporate Results Monitor – 25-08-2023

Aug 25 2023 - Australia
3
Australian Broker Call *Extra* Edition – May 16, 2023

May 16 2023 - Daily Market Reports
4
Australian Broker Call *Extra* Edition – Apr 11, 2023

Apr 11 2023 - Daily Market Reports
5
Australian Broker Call *Extra* Edition – Sep 05, 2022

Sep 05 2022 - Daily Market Reports

Latest Health & Nutrition News

1
Sigma’s Win Not Neccessarily Ebos’ Loss

Jun 14 2023 - Small Caps
2
Sigma Healthcare: Brokers Wary

Mar 31 2022 - Australia
3
Health & Wellness Boom On The ASX

Apr 29 2021 - Weekly Reports
4
M&A Now On Sigma Healthcare’s Agenda

Mar 24 2021 - Australia
5
McPherson’s Expands Into Herbal Health

Nov 04 2020 - Small Caps
6
Nine Ignored Companies Now Worth A Look

Sep 23 2020 - FYI
7
Next Week At A Glance – 14-18 Sep 2020

Sep 11 2020 - Weekly Reports
8
Sigma Farewells API, Heralds New Contract

Dec 17 2019 - Australia
9
Blackmores: Hopes Pinned On Restructuring

Nov 01 2019 - Australia
10
Blackmores Peps Up Its Strategy For China

Apr 17 2019 - Australia